Valacyclovir Hydrochloride丨CAS 124832-27-5

Valacyclovir Hydrochloride丨CAS 124832-27-5
Product Introduction:
Catalog No.: SS095410
CAS No.: 124832-27-5
Grade/Assay: USP/98.0% to 102.0%
Product Name: Valacyclovir hydrochloride
Molecular Formula: C13H21ClN6O4
Molecular Weight: 360.8
Synonym(s): 9-((2-Hydroxy-ethoxy)methyl)guanine L-valine ester hydrochloride
Send Inquiry
Technical Parameters
Description

Hangzhou Leap Chem Co., Ltd. is one of the most professional manufacturers and suppliers of valacyclovir hydrochloride丨cas 124832-27-5 in China. Welcome to wholesale bulk high quality chemical products at competitive price from our factory. If you have any enquiry about custom service, please feel free to email us.

 

Specifications

 

Grade USP Grade
Characteristics White or almost white, crystalline powder
Assay 98.0% to 102.0%
Identification IR: The IR spectrum is concordant with the reference spectrum of valacyclovir hydrochloride
Chlorides reaction: The aqueous solution yields the reactions characteristic of chlorides
HPLC: According to the chromatogram recorded in the Assay item, the retention time of the major peak of test solution corresponds to the retention time of the major peak of reference solution
Related substances (by HPLC) Any other individual impurity: 0.1% max
Total unspecified Impurities: 0.2% max
Guanine & Acyclovir: 2.0% max
Related Compound A: 0.2% max
D-Valacyclovir: 3.0% max
Total Impurities: 5.0% max
Water 5.0% to 9.0%
Residue on ignition 0.1% max
Heavy Metals 20 ppm max
Specific optical rotation [α]D25 -8.5° to -11.5°
pH 4.0 to 6.0
Specific absorption index From 336~372 at 254 nm (on anhydrous and organic solventless basis)
Residual solvents Ethanol: 5000 ppm max
Dimethyl formamide: 880 ppm max

 

Transport Information

 

Parameter

Specification

UN Number

 

Class

 

Packing Group

 

H.S. Code

2933990099306

Stability & Reactivity

The product is chemically stable under standard ambient conditions.

Storage

Keep container tightly closed in a dry and well-ventilated place.

Condition to Avoid

 

Package

 

 

Manufacturing Information

 

Parameter

Specification

Capacity

500kg/month

Frequency

 

Main Export Countries

 

Capacity/Batch

 

Experience

Production since 2016

Stock

 

 

 

 

Applications

 

Valacyclovir hydrochloride is primarily used as an antiviral pharmaceutical for the treatment and management of viral infections caused by herpes viruses. It is commonly prescribed for conditions such as herpes simplex virus (HSV) infections, including genital herpes, cold sores, and shingles (herpes zoster). The compound is also used in prophylactic therapy to reduce the frequency and severity of recurrent outbreaks in patients with chronic herpes infections. In addition, Valacyclovir hydrochloride is applied in research to study antiviral mechanisms, pharmacokinetics, and the development of new nucleoside analogues with improved efficacy and bioavailability.

 

Benefits

 

Valacyclovir hydrochloride offers several advantages due to its chemical structure and pharmacological properties. As a prodrug of acyclovir, it provides significantly improved oral bioavailability, allowing effective systemic antiviral activity at lower doses compared to acyclovir. The compound selectively inhibits viral DNA polymerase, preventing viral replication while exhibiting low toxicity to host cells. Its stability, solubility, and ease of formulation make it suitable for oral administration in tablets or capsules. Additionally, it provides consistent therapeutic effects with a convenient dosing regimen, improving patient compliance and treatment outcomes.

 

Conclusion

 

Valacyclovir hydrochloride is a highly effective antiviral agent with broad applications in the treatment and management of herpes virus infections. Its use in clinical therapy, combined with benefits such as enhanced bioavailability, selective antiviral activity, and patient-friendly dosing, makes it an essential drug in modern antiviral medicine. The compound continues to support effective viral infection management and research into nucleoside-based therapeutics.

 

Send Inquiry
Beyond Your Expectation
From Science to Life with LEAPChem
contact us